| Assessment | Non-Target Sites of Disease | Best Overall Response | ||
| Segment IV liver | Right hilar soft tissue | Pleural effusion | ||
| Cycle 2 | Present | Present | Present | Non-CR/non-PD |
| Cycle 4 | Present | Present | Present | Non-CR/non-PD |
| Cycle 6 | Present | Present | Present | Non-CR/non-PD |
| Cycle 8 | Present | Present | Present | Non-CR/non-PD |
| Cycle 10 | Absent | Present | Present | Non-CR/non-PD |
| Cycle 14 | Absent | Present | Present | Non-CR/non-PD |
| Cycle 18 | Absent | Present | Present | Non-CR/non-PD |
| Cycle 22 | Absent | Present | Present | Non-CR/non-PD |
| Cycle 26 | Absent | Absent | Present | Non-CR/non-PD |
| Cycle 30 | Absent | Absent | Present | Non-CR/non-PD |
| Cycle 34 | Absent | Absent | Present | Non-CR/non-PD |
| Cycle 38 | Absent | Absent | Present | Non-CR/non-PD |